Search results
Jul 18, 2023 · Stand Up To Cancer’s Health Equity Initiative aims to improve disparities in cancer research, screening and treatment. Communities of diverse race and ethnicity, as well as people living in rural communities, are frequently underserved by the health care system. This can result in poorer health outcomes, which is the case with cancer much too ...
Yes, your donation is tax deductible to the fullest extent of the law and you will be emailed a receipt for U.S. tax purposes. What is the Stand Up To Cancer Federal Tax ID number? Stand Up To Cancer is a 501 (c) (3) charitable organization. SU2C’s Federal Tax ID number is 88-4115555.
Stand Up to Cancer ( SU2C) is a charitable program of the Entertainment Industry Foundation (EIF). SU2C aims to raise significant funds for translational cancer research through online and televised efforts. Central to the program is a telethon that was first televised by four major broadcast networks ( ABC, NBC, CBS, Fox) in over 170 countries ...
Stand Up To Cancer enables scientific breakthroughs by funding collaborative, multidisciplinary, multi-institutional scientific cancer research teams and investigators. Thanks to the support of our dedicated partners and the entertainment community, SU2C is able to bring widespread attention to cancer research and treatments. Visit What We Do
Teams may apply for total support up to $800,000 over a term of up to 3 years. The deadline for Full Applications is Monday, July 31, 2023. For more information and to apply, go to Proposal Central, search Stand Up To Cancer under Grant Opportunities, and begin the application process. If you have questions, please contact proposals@su2c.org.
Stand Up to Cancer ( SU2C) is the UK version of Stand Up to Cancer, a US charitable television telethon, broadcast between 2012 and 2018 on the Channel 4 network in the United Kingdom, and again from 2020. The most recent edition of the telethon was on 15 October 2021, [1] a programme which was hosted by Davina McCall, Alan Carr, Maya Jama and ...
Jun 16, 2022 · New sponsorship will fund multidisciplinary teams that aim to remove barriers to cancer clinical trial participation, with a focus on medically underserved communities. LOS ANGELES – June 16, 2022 – Today Stand Up To Cancer® (SU2C) announced a sponsorship from the Janssen Pharmaceutical Companies of Johnson & Johnson aimed at increasing diversity in Phase 1 and Phase 2 cancer clinical trials.
